Colgate-Palmolive Company CL is anticipated to register prime and bottom-line progress when it experiences third-quarter 2023 numbers on Oct 27, earlier than the opening bell. The Zacks Consensus Estimate for third-quarter revenues is pegged at $4.8 billion, indicating an increase of 8.3% from the prior-year quarter’s reported determine.
The consensus estimate for the corporate’s earnings is pegged at 80 cents per share, suggesting progress of 8.1% from the prior-year quarter’s reported determine. The Zacks Consensus Estimate for earnings per share for the quarter has been unchanged up to now 30 days.
In the final reported quarter, the corporate’s earnings beat the Zacks Consensus Estimate by 2.7%. It has delivered an earnings shock of 1.7%, on common, within the trailing 4 quarters.
Colgate-Palmolive Company Price and EPS Surprise
Colgate-Palmolive Company price-eps-surprise | Colgate-Palmolive Company Quote
Key Aspects to Note
Colgate is anticipated to have benefited from stable client demand for private care, hygiene and home care merchandise. The firm’s deal with innovation, premiumization and digital transformation, together with its model power, is prone to have pushed its third-quarter efficiency. Its prime line is prone to have benefited from its accelerated income progress administration plans.
Colgate’s deal with the premiumization of its Oral Care portfolio by way of main improvements has been proving helpful. Of late, the efficiency of its premium innovation merchandise, together with CO. by Colgate, Colgate Elixir toothpaste and Colgate enzyme whitening toothpaste, has been spectacular. This is anticipated to have boosted natural gross sales progress for its Oral Care business within the to-be-reported quarter.
Our estimate for the corporate’s natural gross sales progress is pegged at 5.8% for the third quarter, pushed by 8.5% progress in pricing, offset by a 2.6% decline in quantity.
Solid momentum within the Hill’s business is anticipated to have delivered gross sales progress within the third quarter. Strength in Hill’s Prescription Diet and Hill’s Science Diet has been aiding the phase’s gross sales. The firm’s Prescription Diet Derm Complete model has been gaining market share, which is prone to have augmented gross sales within the third quarter.
We anticipate Colgate’s Pet Nutrition business to ship year-over-year gross sales progress of 11% to $967.9 million within the third quarter.
The main world client merchandise firm has been aggressively increasing into quicker progress channels, whereas extending the geographic footprint of its manufacturers. CL’s efforts to enhance product availability by way of enhanced distribution throughout current and new markets are prone to have pushed its top-line efficiency. Higher e-commerce demand for its merchandise can also be prone to have augmented its third-quarter gross sales.
However, Colgate has been witnessing near-term headwinds associated to rising uncooked and packaging materials prices, and extra pricing. The incremental pricing actions have been affecting quantity developments, that are prone to have continued within the third quarter of 2023.
On the final reported quarter’s earnings name, the corporate anticipated a barely heightened promotional setting within the again half of the 12 months. Increased promotions are prone to have weighed on the corporate’s prime and bottom-line performances within the to-be-reported quarter.
Although CL famous that there was a gradual restoration in cost inflation throughout many areas, nations like Turkey, Argentina and Pakistan have been witnessing excessive inflation charges. These are prone to have partly offset top-line progress within the third quarter.
Given the corporate’s substantial worldwide operations, foreign-currency woes are anticipated to have harm its prime line within the third quarter. We count on foreign money to negatively influence income progress by 1.1% within the to-be-reported quarter.
What the Zacks Model Unveils
Our confirmed mannequin conclusively predicts an earnings beat for Colgate this time round. The mixture of a constructive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) will increase the possibilities of an earnings beat. You can uncover the most effective shares to purchase or promote earlier than they’re reported with our Earnings ESP Filter.
Colgate has a Zacks Rank #3 and an Earnings ESP of +0.37%.
Other Stocks Poised to Beat Earnings Estimates
Here are another corporations that even have the precise mixture of parts to put up an earnings beat:
e.l.f. Beauty ELF at the moment has an Earnings ESP of +0.42% and sports activities a Zacks Rank #1. The firm is anticipated to register year-over-year prime and bottom-line progress when it experiences third-quarter 2023 outcomes. The Zacks Consensus Estimate for e.l.f. Beauty’s quarterly revenues is pegged at $197.3 million, calling for progress of 61.2% from the determine reported within the prior-year quarter.
You can see the whole checklist of right now’s Zacks #1 Rank shares right here.
The Zacks Consensus Estimate for ELF’s quarterly EPS is pegged at 54 cents, indicating an enchancment of fifty% from the year-ago quarter. e.l.f. Beauty has an earnings shock of 108.3% within the final reported quarter.
Church & Dwight Co. CHD at the moment has an Earnings ESP of +5.00% and a Zacks Rank #3. The firm’s prime line is anticipated to extend 12 months over 12 months when it experiences third-quarter outcomes. The Zacks Consensus Estimate for CHD’s quarterly revenues is pegged at $1.43 billion, suggesting an increase of 8.7% from the determine reported within the prior-year quarter.
The Zacks Consensus Estimate for Church & Dwight’s quarterly EPS is pegged at 68 cents, which signifies a ten.5% decline from the year-ago reported determine. CHD has a trailing four-quarter earnings shock of 12.1%, on common.
Molson Coors TAP at the moment has an Earnings ESP of +0.89% and a Zacks Rank #3. TAP is prone to register prime and bottom-line 12 months over 12 months progress when it experiences the third-quarter 2023 numbers. The Zacks Consensus Estimate for its quarterly revenues is pegged at $3.25 billion, which suggests progress of 10.6% from the determine reported within the prior-year quarter.
The Zacks Consensus Estimate for Molson Coors’ quarterly earnings is pegged at $1.52 per share, suggesting a rise of 15.2% from the year-ago quarter’s reported quantity. TAP has delivered an earnings beat of 34.2%, on common, within the trailing 4 quarters.
Stay on prime of upcoming earnings bulletins with the Zacks Earnings Calendar.
Want the latest suggestions from Zacks Investment Research? Today, you’ll be able to obtain 7 Best Stocks for the Next 30 Days. Click to get this free report
Colgate-Palmolive Company (CL) : Free Stock Analysis Report
Church & Dwight Co., Inc. (CHD) : Free Stock Analysis Report
Molson Coors Beverage Company (TAP) : Free Stock Analysis Report
e.l.f. Beauty (ELF) : Free Stock Analysis Report
